Meeting of the National Advisory Council on Nurse Education and Practice, 63288 [2020-22208]
Download as PDF
63288
Federal Register / Vol. 85, No. 195 / Wednesday, October 7, 2020 / Notices
copyright protected. FDA has verified
the website address, as of the date this
document publishes in the Federal
Register, but websites are subject to
change over time.
1. Ridley, D.B., H.G. Grabowski, and J.L. Moe,
‘‘Developing Drugs for Developing
Countries,’’ Health Affairs, vol. 25, no. 2,
pp. 313–324, 2006, available at: https://
www.healthaffairs.org/doi/full/10.1377/
hlthaff.25.2.313.
Dated: October 2, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2020–22191 Filed 10–2–20; 4:15 pm]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the National Advisory
Council on Nurse Education and
Practice
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
ACTION:
Notice; correction.
The National Advisory
Council on Nurse Education and
Practice (NACNEP) meeting scheduled
for Wednesday, December 2, 2020, from
8:30 a.m. to 5:00 p.m. and Thursday,
December 3, 2020, from 8:30 a.m. to
2:00 p.m. Eastern Time has changed its
format. The meeting will now be a
webinar and conference call only. The
webinar link, conference dial-in
number, meeting materials, and updates
will be available on the NACNEP
website: https://www.hrsa.gov/advisorycommittees/nursing/meetings.html.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Camillus Ezeike, Ph.D., JD, LLM, RN,
PMP, Designated Federal Officer,
NACNEP, Bureau of Health Workforce,
Division of Nursing and Public Health,
HRSA, 5600 Fishers Lane, Rockville,
Maryland 20857; 301–443–2866; or
BHWNACNEP@hrsa.gov.
Correction: [This meeting will be a two day
webinar and conference call only, rather than
a two day in-person meeting as previously
announced.]
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–22208 Filed 10–6–20; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
17:21 Oct 06, 2020
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; NCCIH Training and
Education Review Panel (CT).
Date: November 12–13, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NCCIH, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jessica Marie McKlveen,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
Activities, NCCIH, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, MD 20892–
547, jessica.mcklveen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS–CoV–2) and
Coronavirus Disease 2019 (COVID–19).
Date: October 15, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F50,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Ruth S. Grossman, DDS,
Scientific Review Officer, Office Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12J, Bethesda, MD
20892, grossmanrs@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 1, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22109 Filed 10–6–20; 8:45 am]
BILLING CODE 4140–01–P
Dated: October 1, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–22110 Filed 10–6–20; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute on Aging; Notice of
Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
E:\FR\FM\07OCN1.SGM
07OCN1
Agencies
[Federal Register Volume 85, Number 195 (Wednesday, October 7, 2020)]
[Notices]
[Page 63288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22208]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the National Advisory Council on Nurse Education and
Practice
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The National Advisory Council on Nurse Education and Practice
(NACNEP) meeting scheduled for Wednesday, December 2, 2020, from 8:30
a.m. to 5:00 p.m. and Thursday, December 3, 2020, from 8:30 a.m. to
2:00 p.m. Eastern Time has changed its format. The meeting will now be
a webinar and conference call only. The webinar link, conference dial-
in number, meeting materials, and updates will be available on the
NACNEP website: https://www.hrsa.gov/advisory-committees/nursing/meetings.html.
FOR FURTHER INFORMATION CONTACT: Camillus Ezeike, Ph.D., JD, LLM, RN,
PMP, Designated Federal Officer, NACNEP, Bureau of Health Workforce,
Division of Nursing and Public Health, HRSA, 5600 Fishers Lane,
Rockville, Maryland 20857; 301-443-2866; or [email protected].
Correction: [This meeting will be a two day webinar and
conference call only, rather than a two day in-person meeting as
previously announced.]
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-22208 Filed 10-6-20; 8:45 am]
BILLING CODE 4165-15-P